| scholarly article | Q13442814 |
| P50 | author | Ana Isabel Martín | Q46087074 |
| Asunción López-Calderón | Q46087110 | ||
| P2093 | author name string | Carmen Fernández-Galaz | |
| María Ángeles Villanúa | |||
| María Paz Nieto-Bona | |||
| Ana Belen Gómez-SanMiguel | |||
| P2860 | cites work | The melanocortin system in control of inflammation. | Q55426694 |
| Comparison of the effects of the n-3 polyunsaturated fatty acid eicosapentaenoic and fenofibrate on the inhibitory effect of arthritis on IGF1 | Q59708802 | ||
| Fenofibrate, a PPARα agonist, decreases atrogenes and myostatin expression and improves arthritis-induced skeletal muscle atrophy | Q59708806 | ||
| Ghrelin receptor agonist GHRP-2 prevents arthritis-induced increase in E3 ubiquitin-ligating enzymes MuRF1 and MAFbx gene expression in skeletal muscle | Q59708869 | ||
| Influence of chronic restraint stress on proopiomelanocortin mRNA and β-endorphin in the rat hypothalamus | Q67832120 | ||
| The neuropeptide alpha-melanocyte-stimulating hormone inhibits experimental arthritis in rats | Q70805017 | ||
| Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass | Q74268345 | ||
| Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis | Q84724083 | ||
| Skeletal muscle autophagy: a new metabolic regulator | Q26866957 | ||
| Cellular and molecular mechanisms of muscle atrophy | Q27012762 | ||
| Distribution of cDNA for melanocortin receptor subtypes in human tissues | Q28297582 | ||
| Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression | Q28565720 | ||
| FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells | Q29614482 | ||
| Association between periodontal disease and inflammatory arthritis reveals modulatory functions by melanocortin receptor type 3. | Q30834108 | ||
| αMSH blunts endotoxin-induced MuRF1 and atrogin-1 upregulation in skeletal muscle by modulating NF-κB and Akt/FoxO1 pathway | Q34247135 | ||
| Expression of NF-kappaB and IkappaB proteins in skeletal muscle of gastric cancer patients | Q35111740 | ||
| The effect of disease activity on body composition and resting energy expenditure in patients with rheumatoid arthritis | Q35557429 | ||
| Melanocortin-3 receptor regulates the normal fasting response | Q36061409 | ||
| Temporal development of muscle atrophy in murine model of arthritis is related to disease severity | Q37176478 | ||
| Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases | Q37210818 | ||
| Role of IGF-I in skeletal muscle mass maintenance | Q37591648 | ||
| Lipopolysaccharide stimulates p62-dependent autophagy-like aggregate clearance in hepatocytes | Q37603188 | ||
| Glucocorticoid-induced skeletal muscle atrophy | Q38117492 | ||
| Alpha-melanocyte stimulating hormone ameliorates disease activity in an induced murine lupus-like model | Q39223279 | ||
| The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). | Q40457702 | ||
| IKKbeta/NF-kappaB activation causes severe muscle wasting in mice | Q40505119 | ||
| Differential role of melanocortin receptor subtypes in cachexia | Q40563441 | ||
| Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. | Q41007901 | ||
| The diminishment of experimental autoimmune encephalomyelitis (EAE) by neuropeptide alpha-melanocyte stimulating hormone (alpha-MSH) therapy | Q41975249 | ||
| Effect of MTII on food intake and brain c-Fos in melanocortin-3, melanocortin-4, and double MC3 and MC4 receptor knockout mice | Q42391445 | ||
| alpha-MSH and gamma-MSH inhibit IL-1beta induced activation of the hypothalamic-pituitary-adrenal axis through central melanocortin receptors | Q42469352 | ||
| Melanocortins protect against multiple organ dysfunction syndrome in mice | Q42618304 | ||
| COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production | Q43879207 | ||
| Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. | Q44183289 | ||
| Redundancy of a functional melanocortin 1 receptor in the anti-inflammatory actions of melanocortin peptides: studies in the recessive yellow (e/e) mouse suggest an important role for melanocortin 3 receptor | Q44355418 | ||
| Skeletal Muscle wasting and contractile performance in septic rats. | Q44710970 | ||
| Systemic IGF-I administration attenuates the inhibitory effect of chronic arthritis on gastrocnemius mass and decreases atrogin-1 and IGFBP-3. | Q44803921 | ||
| Title efficacy of phosphodiesterase 5 inhibitor on distant burn-induced muscle autophagy, microcirculation, and survival rate | Q44905798 | ||
| Adipose tissue loss in adjuvant arthritis is associated with a decrease in lipogenesis, but not with an increase in lipolysis | Q46677464 | ||
| Systemic α-melanocyte-stimulating hormone administration decreases arthritis-induced anorexia and muscle wasting | Q48117321 | ||
| Antiinflammatory influences of alpha-MSH molecules: central neurogenic and peripheral actions | Q48144120 | ||
| Experimental arthritis inhibits the insulin-like growth factor-I axis and induces muscle wasting through cyclooxygenase-2 activation | Q48281187 | ||
| Muscle wasting in collagen-induced arthritis and disuse atrophy. | Q51188121 | ||
| Protein metabolism and gene expression in skeletal muscle of critically ill patients with sepsis. | Q54351308 | ||
| IGF-I system, atrogenes and myogenic regulatory factors in arthritis induced muscle wasting. | Q54741209 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 79-89 | |
| P577 | publication date | 2015-05-11 | |
| P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
| P1476 | title | The melanocortin receptor type 3 agonist d-Trp(8)-γMSH decreases inflammation and muscle wasting in arthritic rats | |
| P478 | volume | 7 |
| Q47568983 | An analysis of the types of recently published research in the field of cachexia. |
| Q47132964 | Casting the net broader to confirm our imaginations: the long road to treating wasting disorders |
| Q61807299 | Contemporary publication patterns in the Journal of Cachexia, Sarcopenia and Muscle by type and sub-speciality: facts and numbers |
| Q36017471 | D-TRP(8)-γMSH Prevents the Effects of Endotoxin in Rat Skeletal Muscle Cells through TNFα/NF-KB Signalling Pathway |
| Q39721900 | Formoterol decreases muscle wasting as well as inflammation in the rat model of rheumatoid arthritis |
| Q99635754 | Repository corticotropin injection attenuates collagen-induced arthritic joint structural damage and has enhanced effects in combination with etanercept |
Search more.